Week 286 Review - Misery as the yo-yo strikes again

I'm getting fed up of these massive swings every week. Just as I think things are finally going OK they plunge to a massive loss again. Almost all last week's gains were wiped out as my portfolio crashed by £10,176 to go back into the red with a deficit between cost and value of £8.957. The total value dropped to £120,646.

So, it's a deep breath before we hurtle into abject misery.

JLP:Jubilee Metals was the biggest loser this week, dropping 24% in a combination of profit taking and people getting jitters because they always manage to do something stupid just as things start looking good. This week it was a pitiful publicity stunt as the two main directors bought back a measly 500,000 shares after selling millions the week before. It's a real worry that they thought this was a good idea. They may as well have just waited to cash in their options.

FXPO:Ferrexpo paid out a nice special dividend of £35 taking their total divi to £101 in less than a year. That's a nice 10% on top of the 55% growth so far. Shame they dropped 16% this week else they would have been quids in for Share of the Week.

IQE:IQE had a major stutter this week and dropped 10%. It may take longer than I thought before I can sell the trading pot.

OPTI:Optibiotix fell 6p and contributed £8,000 of this week's losses. Here was me eyeing up 84p so I could sell the ones in my share account, but no chance. Back we go below 60p after knocking on resistance and failing to break through yet again.

CAML:Central Asia Metals had another bad week and are sinking like a brick. Another 5% this week, but I think it's a general mailaise as lots of shares have dropped by the same amount.

So many have dropped by 5% that I couldn't be bothered trying to explain why. They all dropped because it's been a shit week on the market. CMCL:Caledonia Mining, HUM:Hummingbird Resources, PAY:Paypoint and POLR:Polar Capital Holdings all fell by 5%.

There is no Share of the Week this week as none of them deserve it. A few managed a feeble 1% gain but everything else is flat or down. It really was a rubbish week

Pleh!

I usually witter on about being above the trend line, but can't be bothered.

Here's the ISA and shares portfolio after week 26 of year 6

			Weekly Change
Cash	£32.95		+£0
Portfolio cost	£63,009.29		+£0
Portfolio sell value (bid price-commission)	£58,142.97	(-7.7%)	-£5,576.31
Potential profits	£7,666.04		-£2,237.57
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 projected avg monthly profit	£94.88	(2.7%)	-£3.80
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£334.94	(9.6%)	-£1.18
(Sold stocks profit + Dividends - Fees  / Months)
Compound performance	53%		+0%

Great big drop and profits hammered as JLP:Jubilee Metals lost £1,000 and all OPTI:Optibiotix profits vanished.

Not as low as 2 weeks ago.

Which direction will we go next week?

The SIPP looks like this after week 270 overall and week 10 of year 6.

			Weekly Change
Cash	£326.87		+£40.94
Portfolio cost	£63,621.21		+£0
Portfolio sell value (bid price - commission)	£60,014.40	(-5.7%)	-£4,524.30
Potential profits	£4,101.03		-£819.43
Yr 6 Dividends	£419.17		+£40.94
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£2,172.89		+£0
Yr 6 projected avg monthly profit	£1,108.79	(33.2%)	-£103.48
Total Dividends	£2,486.25		+£40.94
Total Interest	£0.20		+£0
Total Profit from sales	£17,632.33		+£0
Average monthly cash profit	£312.90	(9.4%)	-£1.16
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	49%		+1%

Nice dividends from FXPO:Ferrexpo and CMCL:Caledonia Mining, and the drop in potential profits isn't quite as bad as the ISA because OPTI:Optibiotix was still loss making last week. 

This account dropped lower than it was 2 weeks ago.

Only just lower though.

The trading account looks like this after week 236 overall and week 28 of year 5

			Weekly Change
Cash	£249.58		+£0
Portfolio cost	£2,364.43		+£0
Portfolio sell value (bid price - commission)	£1,879.92	(-20.5%)	-£76.01
Potential profits	£0		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£631.65		+£0
Yr 5 projected avg monthly profit	£99.64	(50.6%)	-£3.69
Dividends	£60.10		+£0
Profit from sales	£918.02		+£0
Average monthly cash profit	£17.96	(9.1%)	-£0.08
(Sold stocks profit + Dividends - Fees  / Months)

Great big drop of £76 just as it was looking like I was getting the hang of this. No prospect of selling anything for a while now.

A bad few weeks.

Almost touching the trend line. I never expect this account to trend upwards - flat would be ideal once I'm a bit closer to break-even.

So I timed my big purchase with my £4,500 really badly and what's worse is SBTX:SkinBioTherapeutics continues to grow. It's grown so much that the market cap now exceeds OPTI:Optibiotix despite OPTI owning 25% of the company and being at least a year closer to profitability. Hopefully the problem is OPTI being too low rather than SBTX being too high, although if they do drop I'll be able to buy back in.

Week 285 Review - Boing! Back in the black

A complete reversal of last week, with OPTI:Optibiotix recovering all losses whereas my other shares didn't fare so well. The result was an increase in value of £10,958 to go back into profit by £1,218 and increase overall portfolio and cash value to £130,782.

Worst performer was ITX:Itaconix, but that's because I doubled my holding and effectively halved the percentage gain. It fell by 38% but is still 38% up as it had been 76% up which was flat with last week.  I'm fairly staggered with the number of products they are in, and even though there are some red flags in the finances, the profits that will come from being in so many products ought to sort them out.I bought 7,440 shares at 6.72p costing £508.92.

Next worst performer was FXPO:Ferrexpo which dropped 11%. That's on the back of a 5% drop last week. However, I noticed on my account that they went ex-dividend on 14th January for a special dividend which will be paid next Thursday, so some of the sell off could be those getting out after qualifying for the dividend.A bit of a bonus as I didn't spot the announcement in the last trading update. It should be worth about £36.

Unfortunately my next worst performer was CAML:Central Asia Metals, dropping 6% after a 16% fall last week. I can only assume this is traders taking profits after the recent massive rise, but unfortunately it happened just before my trading account holding was high enough to sell. I guess I can wait a few more weeks.

The final big faller this week was ITV:ITV which lost 5%. I suspect this is another case of people selling due to the recent sustained rise. They are still 49% up so I'm happy with that. Re-instatement of the dividend would be my main wish because magic formula shares are meant to earn dividends. I've already had around £250 dividends from the combined magic formula portfolio in the last six months which is 3.6% of the £7,000 and way better than I'd get in a building society.

CMCL:Caledonia Mining actually dropped this week, but I invested another £1,000 buying 87 shares at 1,137.5p costing £998.58. By doubling my holding in a loss making share I effectively halved my deficit from 23% down to only 13%. This was part of me blowing all the cash I had reserved for SBTX:SkinBioTherapeutics when their share price went crazy and it became clear they would not be back at my preferred price for some time. I'm not holding cash that long so put it into shares I think are about to rally. CMCL have a P/E ratio of 4.2 which is utterly crazy given they are paying increasing monthly dividends, the next one of which is due for payment on Friday after going ex dividend on Thursday. I missed it by a day with the new shares but got a good price.

IQE:IQE have been gradually sneaking up and climbed another 13% this week. My ISA holding is now 14% up and making £304 potential profit. This is now my SBTX:SkinBioTherapeutics pot. I'll sell at around 100p and hold the cash for when SBTX drops back to 20p.

Share of the Week is OPTI:Optibiotix which gained back all of last week's 9p drop to climb by 14% back into profit of £500. I got so excited by the bullish signals coming from chartists and from the bottleneck of news predicted to break over the next few months that I used half my SBTX:SkinBioTherapeutics cash to buy another 3,032 at 65.9454p costing £2,008.41. This is the first time in a very long time that I have slightly increased my average price, but only by a fraction as my average is around 64p.The purchase took my holding to just over 130,000 shares.

The red line went back up due to re-investing the cash and the green line is now above it - huzzah!

Granted we're only just over the zero line...

Here's the ISA and shares portfolio after week 25 of year 6

			Weekly Change
Cash	£32.95		+£0
Portfolio cost	£63,009.29		+£0
Portfolio sell value (bid price-commission)	£63,719.28	(1.1%)	+£6,759.13
Potential profits	£9,903.61		+£1,211.95
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 projected avg monthly profit	£98.68	(2.8%)	-£4.11
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£336.12	(9.7%)	-£1.18
(Sold stocks profit + Dividends - Fees  / Months)
Compound performance	53%		+0%

Fairly quiet apart from the big surge from OPTI:Optibiotix. Both sell value and potential profits are up slightly less than they fell last week, mainly thanks to a 2% drop for JLP:Jubilee Metals.

Not a record high, but back on the right side of the red line which I thought might take longer than this to achieve after the massive drop last week.

I shudder to think what will happen next week...

The SIPP looks like this after week 269 overall and week 9 of year 6.

			Weekly Change
Cash	£285.93		-£4,523.75
Portfolio cost	£63,621.21		+£4,527.75
Portfolio sell value (bid price - commission)	£64,538.70	(1.4%)	+£4,194.84
Potential profits	£4,920.46		-£705.41
Yr 6 Dividends	£378.23		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£2,172.89		+£0
Yr 6 projected avg monthly profit	£1,212.27	(36.3%)	-£151.54
Total Dividends	£2,445.31		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£17,632.33		+£0
Average monthly cash profit	£312.90	(9.4%)	-£1.16
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	48%		+0%

Nearly all the cash was piled into shares, and the value went up by an extra £4,194 on top of that. OPTI:Optibiotix is still loss making in this account so didn't contribute enough to profits to mitigate the drop of CAML:Central Asia Metals, FXPO:Ferrexpo and ITV:ITV.

I've already mentioned the purchases in ITX:Itaconix, OPTI:Optibiotix and CMCL:Caledonia Mining. I also bought some more DDDD:4D Pharma as I think they could have a significant re-rate after the Nasdaq listing. I may top slice some of these to get back to £4K worth of SBTX:SkinBioTherapeutics if they ever drop in price again, but I really want a decent amount of DDDD to hold long term. I bought 861 shares at 116.0152p costing £1,007.84. My combined holding is down by 8% but hopefully not for long.

This account has just about managed to stay above the green line on this chart thanks to last week's big cash buffer.

This chart didn't have the benefit of cash, and is also quite revealing that we're not in anywhere near as good shape as we were 2 weeks ago.

The trading account looks like this after week 235 overall and week 27 of year 5

			Weekly Change
Cash	£249.58		+£0
Portfolio cost	£2,364.43		+£0
Portfolio sell value (bid price - commission)	£1,955.93	(-17.3%)	+£4.34
Potential profits	£0		+£0
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£631.65		+£0
Yr 5 projected avg monthly profit	£103.33	(52.4%)	-£3.98
Dividends	£60.10		+£0
Profit from sales	£918.02		+£0
Average monthly cash profit	£18.04	(9.2%)	-£0.07
(Sold stocks profit + Dividends - Fees  / Months)

Just about as flat as it can get, with a rise in IQE:IQE offset by a drop in CAML:Central Asia Metals. The non-suspended shares are down by 4%, 9%, 16% and 20% with HUM:Hummingbird Resources the one nearest to breaking into profit.

If OPTI:Optibiotix goes on a charge, then I very much look forward to doubling the amount of money in this account and having 10 holdings on the go at once. I really need to get to the point where I'm selling one a week.

If I can hold the green line at this level while the orange line continues to drop as I extract profits, then I'll be very happy indeed.

A long recovery, but definitely a recovery.

So we're back where we were 2 weeks ago and in profit. Happy days that were very short lived last time. Will we see the same happen again or will we hold in profit next week? OPTI:Optibiotix has been pushing at the door for a very long time now, as deal after deal was made. I've always believed that it would break out one day, and when it does the breakout could be spectacular, especially after being held in this trading range for so long. 

If we hadn't have got ahead of ourselves a few years ago and rocketed to 132p I think we would have been on a very gradual climb to 100p by now. That feels like the right price for where we are at the moment given the rapid rate of revenue growth and large pipeline of products being developed with global markets.

Let's hope our time has finally come to fly!

Week 284 Review - Massive crash back to reality

Well it didn't even last a week. There was a massive crash much bigger than last week's gains, and we're firmly back in the red. The combined portfolios dropped by a massive £13,451 which created a deficit of £9,739 between cost and value and reduced overall portfolio value to £119,820. Bugger!

Biggest faller was one of may main holdings CAML:Central Asia Metals. It dropped 16% and I suspect a big reason for the drop is directors either selling some of their shares or exercising options and then immediately selling. That amounted to around 800,000 shares, so was bound to impact the price.

OPTI:Optibiotix lost all last week's gains and dropped by 9p which is 14% and responsible for £11K of this week's drop. I just need to accept that OPTI is doomed to be manipulated like this until sizable profits become a regular feature.

CMCL:Caledonia Mining looked like it had started to climb but dropped 8% this week and demonstrates just how bad my timing can be. They are down 23% altogether and ruining my magic formula performance stats.

JLP:Jubilee Metals dropped 7%, but that's not surprising after recent rises. They were looking good for the week until an RNS on Friday which initially made me want to sell up. However it actually appears to be a cunning way of transferring a convertible loan to shares in order to pay a debt, save on interest and introduce a couple of new institutional investors with the proceeds. The fact that they also cashed in some shares paid in lieu of salary to the directors and sold them at the same time caused unease, but the institutions were willing to buy at no discount so I think if anything it strengthens the shares.

APAX:Apax Global Alpha has been gradually climbing, but this week took a 5% drop. There doesn't seem to be any reason other than a bit of an equities sell-off.

FXPO:Ferrexpo also dropped 5% which may have been because no special dividend was announced in their Q4 production update.

IES:Invinity Energy also dropped 5% for no identifiable reason.

RDT:Rosslyn Data are showing some promise, as they have a system that allows companies to process customs documentation for importing and exporting now we're out of the EU. That could take off quite dramatically. I had written these off a few years ago, but now have a little hope I may at least get my money back. They climbed 5% this week but are still 60% down.

Share of the Week is my new investment ITX:Itaconix which climbed a staggering 45% this week following a 47% increase last week, so they take the title 2 weeks in a row. I'm regretting only investing £500 now as they are already up 76%. I need to decide if these are a keeper or if I take my money and run. Given the sheer number of products their ingredient is in, there is a chance of a big re-rate, but their current finances don't look great and their liabilities far exceed their assets which is a worry. We'll see.

Yuck!

Oh the misery.

The ISA and share portfolios look like this after week 24 of year 6

			Weekly Change
Cash	£32.95		+£0
Portfolio cost	£63,009.29		+£0
Portfolio sell value (bid price-commission)	£56,960.15	(-9.6%)	-£6,773.55
Potential profits	£8,691.66		-£1,307.68
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 projected avg monthly profit	£102.79	(3.0%)	-£4.47
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£337.30	(9.7%)	-£1.19
(Sold stocks profit + Dividends - Fees  / Months)
Compound performance	53%		+0%

A devastating drop, and the big drop of JLP:Jubilee Metals hammered the potential profits. One ray of sunshine is that IQE:IQE are back in the black. They are only up by 1% and £19 potential profit, but given these were meant to be a quick win while I waited to buy more SBTX:SkinBioTherapeutics over a year ago, having the potential to get back my £2,000 without loss if I need the cash is very precious.

I guess the positive news is that we're still closer to the cost line than the injection line.

We're also still well above the trend line.

The SIPP looks like this after week 268 overall and week 8 of year 6.

			Weekly Change
Cash	£4,809.68		+£0
Portfolio cost	£59,093.46		+£0
Portfolio sell value (bid price - commission)	£55,816.11	(-5.5%)	-£6,597.90
Potential profits	£5,625.87		-£1,586.49
Yr 6 Dividends	£378.23		+£0
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£2,172.89		+£0
Yr 6 projected avg monthly profit	£1,363.81	(40.8%)	-£194.83
Total Dividends	£2,445.31		+£0
Total Interest	£0.20		+£0
Total Profit from sales	£17,632.33		+£0
Average monthly cash profit	£314.06	(9.4%)	-£1.18
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	48%		+0%

Exactly the same problem as the ISA, with all last week's profit gains gone and a big deepening of the OPTI:Optibiotix loss. The good news is that 7 of the 14 holdings are in profit.

This paints a slightly rosier picture as the green line includes cash, and in a remarkable feat of discipline I've not spent my SBTX:SkinBioTherapeutics pot on anything else yet, so still have £4,000 cash. Once I spend it the red line will zoom up but the green line will stay put.

This gives a better indication of the scale of the drop, but we're above the trend line which is always good.

The trading account looks like this after week 234 overall and week 26 of year 5

			Weekly Change
Cash	£249.58		-£508.74
Portfolio cost	£2,364.43		+£508.74
Portfolio sell value (bid price - commission)	£1,951.59	(-17.5%)	-£80.34
Potential profits	£0		-£40.39
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£631.65		+£0
Yr 5 projected avg monthly profit	£107.31	(54.5%)	-£4.29
Dividends	£60.10		+£0
Profit from sales	£918.02		+£0
Average monthly cash profit	£18.11	(9.2%)	-£0.08
(Sold stocks profit + Dividends - Fees  / Months)

I went for HUM:Hummingbird Resources with my cash pot and bought 1,567 shares at 31.895p costing £508.74. Now I'm trading more frequently I've got a £3 reduction in commission. The price hasn't really moved since I bought them, and the bid price is 31.5p so just 5% down on spread and commission. I thought gold was about to get back above £2,000 but it doesn't seem to be happening. I still think these are under priced and due for a re-rate soon.

All my CAML:Central Asia Metals potential profits vanished so I just have to hope it was a blip and we'll be back on the move again soon, as OPTI:Optibiotix has dropped enough for another go in the trading account but I need to sell something first.

The cost is back up to its normal level. I wish TALY:Tally would come out of suspension as I've been sitting on a load of cash so when I sell them I can get back up to the £2,500 line. Although my new ambition is to get to the £5,000 line when I sell the OPTI:Optibiotix in my share account. That way I get to stay well over 100,000 shares and still top slice a little profit. They just need to get back into the 70p range first though. When I do that I'll bank the BLCC:Block Commodities loss and write off the share account so that only contains my trading shares. I need to try and make £700 profit on the OPTI shares in order to write off the BLCC loss without affecting my performance stats. It would take OPTI getting to 84p to enable that. It would give me £2,500 to add to the trading account and £800 to move into my ISA.

Still well above the trend line.

I was feeling so positive after last week. I thought nothing could stop a nice gradual increase in profits, and I'd be able to put my plan into action to transfer the share account OPTI shares to my trading account to try and boost my holiday fund. All that hope lies in dust today.

Let's see what next week brings...

Week 283 Review - Combined portfolios back in the black and so is Optibiotix

What a week!

Loads of massive risers, one of which was OPTI:Optibiotix and so the deficit between cost and value was completely wiped out and the combined portfolios went into profit for the first time since April 2019.

The difference between cost and value improved by £11,442 and the portfolios are now £3,712 in profit. The total portfolio value plus cash is a record £133,271.

There was only one share that let the side down, with my new gold miner HUM:Hummingbird Resources dropping 6% to go 8% down altogether. I hope I don't regret this purchase, but it was only a £500 investment.

CMCL:Caledonia Mining have started to rise, and climbed 5% this week. They are still 15% down but I'm hoping that will be recovered as we near the dividend date.

BLU:Blue Star Capital climbed 10% probably on the coat-tails of the cryptocurrency rises. They are still 67% down so a long way to go yet.

OPTI:Optibiotix climbed 7p which is 11% and has gone into profit, but every time this has happened in the past we drop back to 50p before very long. Will we hold on this time? The increase accounted for around £8,750 of the overall rise this week.

JLP:Jubilee Metals is climbing relentlessly and is up by another 14% this week to go 208% up altogether and making £8,972 potential profit. All this is on no news, so when new deals are announced or production updates are issued, we could see further gains.

CAML:Central Asia Metals continues a dramatic recovery, climbing another 18% to go 47% up and making £4,844 potential profit.

FXPO:Ferrexpo also comes into the relentless climber category and is up 32% this week to go 87% up and making £882 potential profit.

Share of the Week is my new buy ITX:Itaconix, which after a 16% drop last week climbed 47% to go 31% into the black with £160 potential profit on my small holding. It feels like this company has hit an inflection point like OPTI:Optibiotix, in that their product is inside so many other products that profit is inevitable. Their production costs are a lot higher that OPTI though, so much more risk.

I needn't have done a special blog post last night - we've still blasted through the red line. What a stunning chart!

I was beginning to think I would never see the line peeking above the water

The ISA and share portfolios look like this after week 23 of year 6

			Weekly Change
Cash	£32.95		-£3.75
Portfolio cost	£63,009.29		+£0
Portfolio sell value (bid price-commission)	£63,733.70	(1.1%)	+£5,780.73
Potential profits	£9,999.34		+£1,627.29
Yr 6 Dividends	£0		+£0
Yr 6 Profit from sales	£591.81		+£0
Yr 6 projected avg monthly profit	£107.26	(3.1%)	-£5.62
Total Dividends	£1,343.15		+£0
Total Profit from sales	£21,018.42		+£0
Average monthly cash profit	£338.49	(9.7%)	-£1.26
(Sold stocks profit + Dividends - Fees  / Months)
Compound performance	53%		+0%

Nice rise into the black, with OPTI:Optibiotix returning to paper profit by £1,027 and JLP:Jubilee Metals increasing potential profit by £600. Just a few weeks ago this still seemed like a long way away. How long will it last?

Only just across the red line, but a joy to behold.

Quite a bounce off the trend line from a few weeks ago.

The SIPP looks like this after week 267 overall and week 7 of year 6.

			Weekly Change
Cash	£4,809.68		+£4,523.24
Portfolio cost	£59,093.46		-£2,719.87
Portfolio sell value (bid price - commission)	£62,414.01	(5.6%)	+£5,602.16
Potential profits	£7,212.36		+£1,633.28
Yr 6 Dividends	£378.23		+£17.73
Yr 6 Interest	£0		+£0
Yr 6 Profit from sales	£2,172.89		+£1,802.30
Yr 6 projected avg monthly profit	£1,558.64	(46.7%)	+£1,042.67
Total Dividends	£2,445.31		+£17.73
Total Interest	£0.20		+£0
Total Profit from sales	£17,632.33		+£1,802.30
Average monthly cash profit	£315.24	(9.4%)	+£28.19
(Sold stocks profit + Dividends - Fees / Months)
Compound performance	48%		+4%

There's a lot going on here!

I sold just under half my SBTX:SkinBioTherapeutics holding yesterday because it went past the point where it usually drops. When it climbed to 31p today I felt it had gone way past where it should be and sold the rest. That decision cost me £150 as the price continued up to 33.5p. I think that's crazy for a company that hasn't got revenues for some time yet, no matter how much I love them. I ended up making £1,802.30 profit and liberated £4,522 which I am determined to hold for when they drop back below 20p.

Knowing my luck they will soar to 100p now. It doesn't matter, I own them by proxy from the OPTI:Optibiotix stake. SBTX is the one share that I am willing to actively trade and risk not being in when they take off properly. Doing so has made me £5,345 profit so far. You could argue I'd lose more than that by not being invested when they re-rate, but it's a risk I'm prepared to take due to my OPTI holding.

There was a £17 dividend from POLR:Polar Capital Holdings this week, somewhat lost amongst everything else.

Potential profits went up despite cashing in SBTX, annual projected performance is crazy, but it expects the first 7 weeks to continue for the rest of the year. If I don't sell anything else for the next 45 weeks then I would end up with 6.3% for this year, which isn't bad. Overall performance was boosted to 9.4%, and now that's measured against injection amount it won't plummet when I re-invest my profits.

Spectacular.

The dark days of April seem a long way away.

The trading account looks like this after week 233 overall and week 25 of year 5

			Weekly Change
Cash	£758.32		+£517.47
Portfolio cost	£1,855.69		-£511.72
Portfolio sell value (bid price - commission)	£1,523.19	(-17.9%)	+£59.32
Potential profits	£40.39		+£40.39
Year 5 Dividends	£12.18		+£0
Year 5 Profit	£631.65		+£65.74
Yr 5 projected avg monthly profit	£111.60	(72.2%)	+£7.22
Dividends	£60.10		+£0
Profit from sales	£918.02		+£65.74
Average monthly cash profit	£18.19	(11.8%)	+£1.15
(Sold stocks profit + Dividends - Fees  / Months)

I sold my OPTI:Optibiotix trading shares for £65.74 (12.6%) profit. I have to admit I got scared because OPTI always drops after getting to break even in my main portfolio. I wasn't wrong as it did drop off a bit after I sold these. I also removed £60 to my bank account for my Madagascar holiday fund, which is why cash is only up just over £500.

Taking into account the sale, the rest f the portfolio gained £59 this week, and CAML:Central Asia Metals went into profit and I may be able to sell them next week. They are on quite a steady rise though, so I may hold a bit longer. Anything over £50 should be seen as a good profit in this account.

Long term performance is spectacular now, with 11.8% over four and a half years really good going. If I can keep up the year 5 performance of over £100 a month over the first six months I'll be very happy.

Note that the green line includes cash, so that will not go up next week when the red line bounces back by £500 when I re-invest the cash. The injection line is dropping beautifully as I take more out.

This is a much more meaningful chart as it sees through all the buying and selling and shows the difference between stock cost and value. Another small tick up despite profit taking, and the trend line is getting steeper upwards.

Here's my wish list:

1. JLP:Jubilee Metals to announce permission to process platinum rich tailings at DCM and the fine chrome plant move is completed and operation. Still nothing, but still the shares climb in value.
   
2. OPTI:Optibiotix Health to get back in profit. Yes! This one can now change to OPTI stays in profit. Some chance!.
3. CMCL:Caledonia Mining reverses the down trend and gets back into profit. A good 5% increase is moving this in the right direction.
   
4. The combined portfolios get back into the black. Yes!

I may abandon the wishes now, as I only have 2 left and they may struggle on for a long time.

One of the best weeks ever, and green all over my spreadsheet. If you add up potential profit and cash it comes to £22,853 which is wonderful. I feel nervous being out of SBTX:SkinBioTherapeutics, but I have a plan and I'm trying to stick to it without letting emotion get in the way. If SBTX does soar, then I should look at it as an opportunity to spend the cash on 4 new magic formula shares instead, as they are proving themselves to be pretty great. Also, if this happens then OPTI:Optibiotix will benefit and I'll be quids in anyway, so I shouldn't fret or wish SBTX drops back below 20p. Well, maybe just a little bit...

Portfolio back in the black for the first time in 19 months!

I had to write something today because it might not last through tomorrow and I want to celebrate. After 19 months, my combined portfolio has broken through the red line and is in profit for the first time since 5th April 2019.

It's been a great few weeks, but today went ballistic, and not only did the combined portfolio go into profit, but OPTI:Optibiotix went into profit too.

Look at that! The green line didn't nudge past the red line gingerly - it blasted a whacking great hole through it.

Last time this happened it didn't survive to the end of the week snapshot, so I wanted a record that it actually happened.

OPTI:Optibiotix climbed 14.9% today and is up by about £650 across all my holdings, which is around 0.8% after 5 years, but hopefully this is just the start.

SBTX:SkinBioTherapeutics had an even better day, climbing 29.8%, and I have to admit I sold almost half my holdings as I didn't think it would last. I sold 7,500 shares at 26.12p and made £658.08 (50.5%) profit. I liberated £1,950.05 and I am determined to be disciplined and hold onto it so I can buy more SBTX when it dips lower again, which it nearly always does. If it doesn't then I still have half my holding and I can play with the cash on something else. I always consider my SBTX holding as a bonus, as I hold so many virtually via OPTI:Optibiotix.

Lots of other shares performing today. JLP:Jubilee Metals up 3% and now my holding is up 210% and making £9,072 potential profit.

CAML:Central Asia Metals is up 5.9% today and 46% up overall, making £4,732 potential profit along with the £1,822 dividends received.

My remining holding in SBTX:SkinBioTherapeutics is still up 55% and making £782 potential profit.

FXPO:Ferrexpo is going mad and up another 2.9% today to go 89% up altogether with £906 potential profit, £65 in dividends so far and a special dividend on the way.

I've had precious few days like this over the last 5 years, so I'm going to make the most of it, as it may not last very long...